Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
AstraZeneca ADR | AZN | 2. jul 2024 | 76.99 | -1.22 |
Astria Therapeutics | ATXS | 2. jul 2024 | 8.97 | -3.03 |
Astronics | ATRO | 2. jul 2024 | 20.35 | +3.35 |
AstroNova | ALOT | 2. jul 2024 | 14.80 | 0.00 |
Astrotech | ASTC | 2. jul 2024 | 8.87 | -2.42 |
Asure Software | ASUR | 2. jul 2024 | 8.25 | -2.02 |
AT&T | T | 2. jul 2024 | 18.82 | -0.84 |
AT&T A Pref | T-A | 2. jul 2024 | 21.14 | +0.93 |
AT&T C Pref | T-C | 2. jul 2024 | 20.31 | +0.89 |
ATA Creativity Global ADR | AACG | 2. jul 2024 | 0.82 | -0.15 |
Atara Biotherapeutics | ATRA | 2. jul 2024 | 7.52 | -10.05 |
Atea Pharmaceuticals | AVIR | 2. jul 2024 | 3.23 | -4.15 |
Aterian | ATER | 2. jul 2024 | 2.76 | +8.66 |
Athena Technology Acquisition II | ATEK | 2. jul 2024 | 11.36 | +0.18 |
Athene A Pref | ATH-A | 2. jul 2024 | 24.26 | +1.55 |
Athene B Pref | ATH-B | 2. jul 2024 | 21.42 | 0.00 |
Athene C Pref | ATH-C | 2. jul 2024 | 24.90 | +0.04 |
Athene D Pref | ATH-D | 2. jul 2024 | 18.64 | +0.22 |
Athene Holding | ATH-E | 2. jul 2024 | 26.02 | +0.58 |
Athira Pharma | ATHA | 2. jul 2024 | 2.52 | +0.40 |
Ati Physical Therapy A | ATIP | 2. jul 2024 | 4.89 | +6.77 |
ATIF Holdings | ATIF | 2. jul 2024 | 0.85 | +2.65 |
Atkore | ATKR | 2. jul 2024 | 131.00 | -1.01 |
Atlanta Braves A | BATRA | 2. jul 2024 | 42.14 | +2.76 |
Atlanta Braves C | BATRK | 2. jul 2024 | 40.44 | +3.59 |
Atlantic American | AAME | 2. jul 2024 | 1.58 | -6.66 |
Atlantic Coastal Acquisition II A | ACAB | 2. jul 2024 | 11.80 | 0.00 |
Atlantic Union Bank | AUB | 2. jul 2024 | 33.33 | +1.83 |
Atlantic Union Bankshares A Pref | AUB-A | 2. jul 2024 | 23.52 | +1.51 |
Atlantica Sustainable Infrastructure | AY | 2. jul 2024 | 21.88 | -0.14 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.